Centene updates full-year guidance in Q1 earnings report

The Clayton-based corporation increased its full-year adjusted diluted earnings per share guidance floor by 10 cents to greater than $6.80.
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Source Type: news